Apply to Win a Chance to Accelerate Your Company with Takeda Canada!
We are launching this call for applications to foster collaborations in digital health and redefine the patient journey. The winner(s) will benefit from:
A dedicated point of contact at Takeda Canada
Direct response about collaboration at the end of the Takeda Canada Innovation Challenge
Takeda’s resources & expertise
Dedicated budget to fund a proof-of-concept project with the winner(s) of the challenge
(subject to maximum funding amount available, approved completion of Takeda’s third-party risk management* due diligence process, and entering into a funding agreement with Takeda Canada)
Opportunity to benefit from Takeda’s internal expertise and international network of partners and suppliers
Why a Digital Health Innovation Challenge?
Takeda Canada is committed to bringing better health and a brighter future to people through leading innovation in medicine. By accelerating the use of digital and data, Takeda Canada wants to speed the delivery of life-saving medicines, while also easing the burden of diagnosis and treatment for patients, their families and healthcare providers.
Innovation across the entire healthcare ecosystem holds the key to fully unlocking the power of digital and data for improved patient outcomes. To make a bigger impact on peoples’ lives, Takeda Canada is opening its doors to new partnerships that will accelerate the future of personalized healthcare.
What Are We Looking For?
Takeda Canada is looking for innovative solutions that could apply to one of these therapeutic areas:
Inflammatory Bowel Disease (Ulcerative Colitis or Crohn's Disease)
No purchase necessary. For full challenge terms and conditions click here.
*A third party risk management process will be performed by Takeda with the prospective winner(s) of the challenge that will evaluate risks related to anti-corruption, information protection, cybersecurity, privacy and other criteria. For more information on the due diligence process see terms and conditions or contact us.